Torrent Pharmaceuticals

Market Cap (₹ Cr.)

₹1,04,737

52 Week High

3,590.70

Book Value

₹203

52 Week Low

2,025.70

PE Ratio

60.19

PB Ratio

13.96

PE for Sector

41.94

PB for Sector

19.70

ROE

24.16 %

ROCE

28.08 %

Dividend Yield

0.90 %

EPS

₹49.44

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Formulations

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

11.59 %

Net Income Growth

33.02 %

Cash Flow Change

37.92 %

ROE

20.25 %

ROCE

27.35 %

EBITDA Margin (Avg.)

6.32 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	998	1,943	1,667	1,094	1,027	1,373	1,117	1,320	1,082	956	1,116	1,121	1,383	1,486	1,580	1,494	1,584	1,634	1,726	1,533	1,512	1,734	1,649	1,627	1,559	1,745	1,853	1,625	1,723	1,962	1,939	1,930	1,946	2,132	2,161	2,112	2,219	2,459	2,427
Expenses	751	689	637	894	771	857	814	943	852	726	789	781	1,040	1,040	1,016	1,030	1,063	1,091	1,071	1,023	1,066	1,117	1,054	1,046	1,037	1,117	1,182	1,161	1,179	1,268	1,308	1,312	1,342	1,384	1,410	1,422	1,427	1,539	1,513
EBITDA	247	1,254	1,030	200	256	516	303	377	230	230	327	340	343	446	564	464	521	543	655	510	446	617	595	581	522	628	671	464	544	694	631	618	604	748	751	690	792	920	914
Operating Profit %	14 %	62 %	58 %	10 %	20 %	33 %	22 %	23 %	7 %	13 %	21 %	23 %	20 %	27 %	29 %	26 %	19 %	30 %	32 %	29 %	27 %	34 %	34 %	35 %	28 %	34 %	33 %	26 %	29 %	32 %	31 %	30 %	29 %	33 %	33 %	32 %	32 %	36 %	36 %
Depreciation	55	52	53	53	55	61	64	68	76	74	78	89	143	141	144	147	147	149	151	152	155	150	153	155	152	150	153	152	147	149	156	185	182	183	192	191	195	189	190
Interest	47	53	48	41	38	48	51	46	57	55	51	71	117	117	120	125	119	117	111	106	96	97	86	87	69	66	64	57	52	51	62	91	94	90	77	69	67	64	54
Profit Before Tax	145	1,149	929	106	163	407	188	263	97	101	198	180	83	188	300	192	255	277	393	252	195	370	356	339	301	412	454	255	345	494	413	342	328	475	482	430	530	667	670
Tax	42	310	246	10	51	87	40	56	39	22	42	39	18	41	57	39	57	60	56	42	34	64	63	60	61	72	79	45	57	86	70	59	59	82	83	75	82	117	139
Net Profit	103	839	683	96	124	337	169	234	114	84	158	20	220	122	277	182	164	223	328	220	168	298	283	278	279	274	326	170	221	327	272	234	219	323	327	297	410	469	460
EPS in ₹	6.12	49.59	40.33	5.66	7.41	19.95	9.96	13.78	6.79	4.97	9.31	1.25	12.95	7.21	16.38	10.73	9.73	13.18	19.40	12.97	9.91	17.63	16.68	16.45	16.48	16.21	19.24	10.06	13.08	19.35	8.02	6.91	6.46	9.55	9.65	8.78	12.12	13.86	13.60

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	6,510	7,289	8,081	11,820	12,027	11,885	11,761	11,153	12,872	12,377
Fixed Assets	2,763	2,681	3,523	7,429	7,425	7,198	6,741	6,251	7,972	7,986
Current Assets	2,732	3,137	3,616	3,639	3,749	3,819	4,142	4,060	3,927	3,741
Capital Work in Progress	628	984	473	447	498	536	588	568	698	226
Investments	283	918	936	625	486	135	314	368	361	463
Other Assets	2,835	2,705	3,148	3,319	3,618	4,016	4,118	3,966	3,841	3,701
Total Liabilities	3,804	3,581	3,627	7,264	7,012	6,764	5,731	4,807	6,416	5,548
Current Liabilities	1,326	1,502	1,184	2,988	3,088	3,387	2,586	2,423	3,409	2,989
Non Current Liabilities	2,478	2,079	2,443	4,276	3,924	3,376	3,145	2,384	3,007	2,559
Total Equity	2,706	3,707	4,454	4,556	5,015	5,121	6,030	6,345	6,456	6,829
Reserve & Surplus	2,621	3,623	4,369	4,472	4,931	5,036	5,945	6,261	6,287	6,660
Share Capital	85	85	85	85	85	85	85	85	169	169

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-38	493	16	-349	-69	294	-325	3	20	19
Investing Activities	-2,099	-584	-533	-4,207	-373	269	-316	-160	-2,326	-296
Operating Activities	1,065	2,403	679	929	1,232	1,580	1,573	2,140	2,265	2,893
Financing Activities	996	-1,326	-131	2,929	-928	-1,555	-1,581	-1,977	81	-2,578

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Jul 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %	71.25 %
FIIs	11.37 %	11.65 %	11.53 %	11.63 %	10.88 %	10.80 %	10.79 %	11.37 %	12.09 %	12.04 %	12.84 %	13.15 %	14.09 %	14.14 %	14.22 %	14.46 %
DIIs	8.35 %	8.42 %	8.72 %	8.94 %	9.73 %	10.01 %	10.08 %	9.51 %	8.87 %	9.00 %	8.31 %	8.00 %	7.21 %	7.26 %	7.27 %	7.08 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	9.03 %	8.68 %	8.50 %	8.18 %	8.14 %	7.95 %	7.88 %	7.88 %	7.80 %	7.71 %	7.60 %	7.60 %	7.45 %	7.36 %	7.26 %	7.21 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Torrent Pharmaceuticals	3,096.00	1,04,737.39	60.19	10,785.75	11.59	1,656	17.36	35.01
Ajanta Pharma	2,943.05	36,719.79	41.97	4,293.31	11.77	816	10.84	44.54
Gland Pharma	1,781.85	29,300.27	42.36	5,834.96	50.97	772	-15.74	54.66
Eris Lifesciences	1,371.60	18,570.27	53.30	2,032.96	19.85	397	-21.22	57.55
Caplin Point Laboratories	1,931.35	14,832.16	30.05	1,761.04	15.65	461	12.63	49.56
Marksans Pharma	307.60	13,860.01	39.93	2,227.83	16.55	315	16.59	59.02
Shilpa Medicare	909.50	8,604.62	149.90	1,159.77	8.64	32	1,042.68	56.47
Jeena Sikho Lifecare	1,929.00	4,768.92	142.84	207.35	40.06	34	-	69.83
Amrutanjan Health Care	709.10	2,084.17	43.85	192.42	12.50	21	72.26	48.21
Hester Biosciences	2,427.35	2,073.08	88.33	315.18	12.07	21	107.67	49.92